These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 11745413)
1. Antitumor action of the PKC activator gnidimacrin through cdk2 inhibition. Yoshida M; Feng W; Nishio K; Takahashi M; Heike Y; Saijo N; Wakasugi H; Ikekawa T Int J Cancer; 2001 Nov; 94(3):348-52. PubMed ID: 11745413 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of antitumor action of PKC activator, gnidimacrin. Yoshida M; Yokokura H; Hidaka H; Ikekawa T; Saijo N Int J Cancer; 1998 Jul; 77(2):243-50. PubMed ID: 9650560 [TBL] [Abstract][Full Text] [Related]
3. Involvement of PKC betaII in anti-proliferating action of a new antitumor compound gnidimacrin. Yoshida M; Heike Y; Ohno S; Ikekawa T; Wakasugi H Int J Cancer; 2003 Jul; 105(5):601-6. PubMed ID: 12740906 [TBL] [Abstract][Full Text] [Related]
4. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells. Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932 [TBL] [Abstract][Full Text] [Related]
5. Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)-independent Cdk2 inhibition in human carcinoma T47D-H3 cells. Bilodeau JF; Faure R; Piedboeuf B; Mirault ME Exp Cell Res; 2000 May; 256(2):347-57. PubMed ID: 10772807 [TBL] [Abstract][Full Text] [Related]
6. Saucernetin-7 isolated from Saururus chinensis inhibits proliferation of human promyelocytic HL-60 leukemia cells via G0/G1 phase arrest and induction of differentiation. Seo BR; Lee KW; Ha J; Park HJ; Choi JW; Lee KT Carcinogenesis; 2004 Aug; 25(8):1387-94. PubMed ID: 15033903 [TBL] [Abstract][Full Text] [Related]
7. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells. Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine. Sampath D; Shi Z; Plunkett W Mol Pharmacol; 2002 Sep; 62(3):680-8. PubMed ID: 12181445 [TBL] [Abstract][Full Text] [Related]
9. G2-phase arrest through p21(WAF1 / Cip1) induction and cdc2 repression by gnidimacrin in human hepatoma HLE cells. Yoshida M; Matsui Y; Iizuka A; Ikarashi Y Anticancer Res; 2009 Apr; 29(4):1349-54. PubMed ID: 19414386 [TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of daphnane-type diterpene gnidimacrin isolated from Stellera chamaejasme L. Yoshida M; Feng W; Saijo N; Ikekawa T Int J Cancer; 1996 Apr; 66(2):268-73. PubMed ID: 8603823 [TBL] [Abstract][Full Text] [Related]
11. The p21(Cip1) protein, a cyclin inhibitor, regulates the levels and the intracellular localization of CDC25A in mice regenerating livers. Jaime M; Pujol MJ; Serratosa J; Pantoja C; Canela N; Casanovas O; Serrano M; Agell N; Bachs O Hepatology; 2002 May; 35(5):1063-71. PubMed ID: 11981756 [TBL] [Abstract][Full Text] [Related]
12. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip). Chen WJ; Chang CY; Lin JK Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329 [TBL] [Abstract][Full Text] [Related]
13. Phosphorylations of cyclin-dependent kinase 2 revisited using two-dimensional gel electrophoresis. Coulonval K; Bockstaele L; Paternot S; Roger PP J Biol Chem; 2003 Dec; 278(52):52052-60. PubMed ID: 14551212 [TBL] [Abstract][Full Text] [Related]
14. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex. Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461 [TBL] [Abstract][Full Text] [Related]
15. p21CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases. Saha P; Eichbaum Q; Silberman ED; Mayer BJ; Dutta A Mol Cell Biol; 1997 Aug; 17(8):4338-45. PubMed ID: 9234691 [TBL] [Abstract][Full Text] [Related]
16. Induction of p53-independent p21 during ceramide-induced G1 arrest in human hepatocarcinoma cells. Kim WH; Kang KH; Kim MY; Choi KH Biochem Cell Biol; 2000; 78(2):127-35. PubMed ID: 10874474 [TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells. Gong J; Ammanamanchi S; Ko TC; Brattain MG Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668 [TBL] [Abstract][Full Text] [Related]
18. Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4. Ding QM; Ko TC; Evers BM Am J Physiol; 1998 Nov; 275(5):C1193-200. PubMed ID: 9814966 [TBL] [Abstract][Full Text] [Related]
20. Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells. Kim SG; Kim SN; Jong HS; Kim NK; Hong SH; Kim SJ; Bang YJ Oncogene; 2001 Mar; 20(10):1254-65. PubMed ID: 11313870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]